Just one place in Australia is hitting hepatitis B treatment targets — this is what it does
When Australia missed its target of treating 20% of chronic hepatitis B patients in 2022, there was one exception. Even in 2023, the national treatment…
When Australia missed its target of treating 20% of chronic hepatitis B patients in 2022, there was one exception. Even in 2023, the national treatment…
A GP expert says this year’s early influenza surge is unsurprising but disappointing as it can be explained partly by Australia’s low vaccination rates. More…
A leading infectious diseases specialist has urged GPs to prescribe nirmatrelvir–ritonavir more readily for patients in aged care facilities, who are still dying of COVID-19…
Patients with COVID-19 will be restricted to telehealth consultations with their regular practice from 1 July after Medicare scraps their exemption to the existing relationship…
Nirmatrelvir-ritonavir is no better than placebo for resolving symptoms in patients who are at low risk for severe COVID-19, results from an international study suggest.…
The Federal Government has rejected a proposal that pharmacists be allowed to sell antiviral treatments for COVID-19 over the counter, saying it would be illegal…
The PBAC has warned that the $981 million annual cost of subsiding COVID-19 antivirals must be curbed with stricter PBS criteria or price cuts for the manufacturers. …
NSW Minister for Health Ryan Park has confirmed that the state’s pharmacy trial will be expanded to allow pharmacists to prescribe treatments for four skin conditions including…
Dr Bronwyn King.“I live a very different life now.” This is Melbourne oncologist Dr Bronwyn King describing what two bouts of COVID-19 did to her and…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.